Effects of Cabozantinib, a small molecule tyrosine kinase inhibitor, on the immune permissiveness of the tumor microenvironment and immune-mediated killing of tumor cells
Anna R Kwilas, Andressa Ardiani, Renee N Donahue, Dana Aftab, James W Hodge
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P185; DOI: 10.1186/2051-1426-2-S3-P185